NMTC (NeuroOne) Return on Sales by Gross Profit

NMTC (NeuroOne Medical Technologies Corp.) - company brandmark

The commercial launch of thin-film electrodes has activated operating leverage, triggering a notable jump in gross margin variance for NeuroOne Medical Technologies (NMTC). High-precision neuromonitoring secures NeuroOne Medical Technologies (NMTC) a leadership position in Parkinson's treatment, and 55.60 represents the current value of the metric. Further progress is based on FDA approvals and the expansion of distribution through strategic partners.

NeuroOne Medical Technologies (NMTC): Gross Margin from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for NeuroOne Medical Technologies (NMTC)

Fundamental valuation:NMTC NeuroOne
Finished products of NeuroOne Medical Technologies Corp.

To assess long-term risks, it is critical for investors to track the portion of revenue remaining after deducting direct production costs, which determines the efficiency of cost-of-goods-sold management. By analyzing the growth rate of the gross margin, one can gauge the operational resilience of NeuroOne Medical Technologies (NMTC) as it scales the supply of high-tech neuromodulation electrodes within the B2B segment, where high margins confirm the technological advantage and market value of the products.

Main competitors

BSX - Return on Sales by Gross Profit|EW (Edwards) - Gross Margin|Return on Gross Profit ResMed Corp (RMD)|Gross Margin PODD|Gross Margin zimmerbiomet.com (ZBH)|Gross Profitability CooperCompanies COO|Gross Margin Invisalign ALGN|GMED - Gross Profitability|TMDX: Gross Profitability|ATEC (Alphatec Holdings, Inc.) - Return on Gross Profit|Artivion, Inc. - Gross Profit Rate|ENOV (Enovis Inc.) - Gross Margin|Gross Profit Margin Integra LifeSciences Corp IART|Gross Profitability Establishment Labs Corp (ESTA)|Beta Bionics Inc (BBNX) - Gross Sales Margin|IRADIMED Inc. - Return on Gross Profit|Gross Margin Embecta Corp. EMBC|Tandem Diabetes Care Inc - Gross Margin|Return on Sales by Gross Profit AxoGen Inc AXGN|SI-BONE (SIBN) - Gross Profitability|Gross Profitability Margin OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Gross Margin|Return on Gross Profit OrthoPediatrics Corp. (KIDS)|Gross Margin TMCI|SRTA - Gross Profit Margin|Gross Profitability Carlsmed Inc CARL|RXST: Gross Return on Sales|CLPT: Return on Gross Profit|stereotaxis.com - Gross Profit Ratio|NeuroStar (STIM) - Gross Profitability|SGHT - Return on Sales by Gross Profit|Gross Profitability Orchestra BioMed|Gross Return on Sales ANIK (Anika Therapeutics)|Gross Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Gross Return on Sales|Gross Margin VANI (Vivani Medical Inc)|XTNT: Gross Return on Sales|MODD - Gross Profitability|Gross Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Gross Profit|Vivos Therapeutics, Inc. - Gross Profit Rate|Gross Profitability enVVeno Corp|SINT (Sintx Technologies) - Gross Profit Ratio|Gross Margin TNON|LFWD (Lifeward Ltd.) - Gross Profit Rate|autonomix.com - Return on Gross Profit|Return on Sales by Gross Profit invobioscience.com (IVF)|BBLG - Gross Profitability|AXNX (Axonics) - Gross Return on Sales|BIOL: Gross Margin|DYNT - Return on Sales by Gross Profit|FNA (paragon28.com) - Gross Margin|Gross Profit Margin invobioscience.com INVO